Amdocs (NASDAQ:DOX) Reaches New 12-Month Low – Should You Sell?

Amdocs Limited (NASDAQ:DOX)’s stock price reached a new 52-week low during trading on Wednesday . The stock traded as low as $63.33 and last traded at $63.69, with a volume of 1673219 shares traded. The stock had previously closed at $65.10.

Analyst Ratings Changes

DOX has been the topic of several analyst reports. Wall Street Zen cut Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Barclays cut their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, February 4th. Stifel Nicolaus decreased their price objective on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $92.33.

Amdocs Price Performance

The stock’s 50-day moving average is $71.85 and its 200 day moving average is $77.97. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. The stock has a market capitalization of $7.10 billion, a PE ratio of 12.72, a P/E/G ratio of 1.16 and a beta of 0.42.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The firm had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.15 billion. During the same period in the previous year, the company earned $1.66 earnings per share. Amdocs’s quarterly revenue was up 4.1% compared to the same quarter last year. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, equities analysts expect that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be given a $0.569 dividend. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.5%. Amdocs’s payout ratio is currently 40.81%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Amundi boosted its holdings in shares of Amdocs by 73.0% in the first quarter. Amundi now owns 13,778 shares of the technology company’s stock valued at $1,217,000 after acquiring an additional 5,816 shares during the period. Millennium Management LLC raised its position in Amdocs by 458.3% in the 1st quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock valued at $6,135,000 after purchasing an additional 55,038 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in Amdocs by 12.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock worth $30,300,000 after purchasing an additional 37,087 shares during the period. Empowered Funds LLC boosted its stake in Amdocs by 12.0% during the 1st quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock worth $1,462,000 after purchasing an additional 1,709 shares during the period. Finally, Jane Street Group LLC grew its position in Amdocs by 195.4% during the 1st quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock worth $10,608,000 after purchasing an additional 76,683 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.